Effective Date Contract Clauses (1,718)

Grouped Into 63 Collections of Similar Clauses From Business Contracts

This page contains Effective Date clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Effective Date. Except as otherwise provided herein, this Agreement shall be deemed effective as of such date as the Company and the Holder shall have duly executed and delivered this Agreement (the "Effective Date").
Effective Date. Except as otherwise provided herein, this Agreement shall be deemed effective as of such date as the Company and the Holder Investor shall have duly executed and delivered this Agreement (the "Effective Date").
View Variation
Effective Date. The Plan's effective date is the date on which it is adopted by the Board, so long as it is approved by the Company's stockholders at any time within 12 months of such adoption. Upon approval of the Plan by the stockholders of the Company, all Awards issued pursuant to the Plan on or after the Effective Date shall be fully effective as if the stockholders of the Company had approved the Plan on the Effective Date. If the stockholders fail to approve the Plan within one year before or after the E...ffective Date, any Awards made hereunder shall be null and void and of no effect. View More
Effective Date. The Plan's effective date is the date on which it is adopted by the Board, so long as it is approved by the Company's stockholders at any time within 12 twelve (12) months of such adoption. Upon approval of the Plan by the stockholders of the Company, all Awards issued pursuant to the Plan on or after the Effective Date shall be fully effective as if the stockholders of the Company had approved the Plan on the Effective Date. If the stockholders fail to approve the Plan within one year before or... after the Effective Date, any Awards made hereunder shall be null and void and of no effect. 11 18. Term of Plan. The Plan will terminate 10 years following the earlier of (i) the date it was adopted by the Board or (ii) the date it became effective upon approval by stockholders of the Company, unless sooner terminated by the Board pursuant to Section 19. View More
View Variation
Effective Date. You may revoke this Agreement for a period of seven (7) days following the day you sign it. If you choose to revoke this Agreement following execution, you must do so in writing, the writing must be received by Diffusion via e-mail to the Company's General Counsel, and it must be received by Diffusion within that seven (7) day period. Accordingly, this Agreement shall not become effective or enforceable until 12:00 a.m. on the eighth (8th) day following your signature hereof (the "Effective Date..."). [Remainder of Page Intentionally Left Blank] By signing this Agreement, you acknowledge that you have carefully reviewed this Agreement, that you have had an opportunity to consult with counsel of your choice, that you have entered into this Agreement freely and voluntarily and without reliance on any promises not expressly contained herein, that you have been afforded an adequate time to review carefully the terms of this Agreement, and that this Agreement will not be deemed void or avoidable by claims of duress, deception, mistake of fact or otherwise. Sincerely, DIFFUSION PHARMACEUTICALS INC. /s/ Robert J. Cobuzzi Robert J. Cobuzzi, Jr., Ph.D. Chief Executive Officer I have reviewed the Agreement as set forth above, I understand the Agreement, and, intending to be legally bound by my signature below, knowingly, and voluntarily accept all its terms and conditions. /s/ Christopher D. Galloway March 1, 2023 Name: Christopher D. Galloway, M.D. Date EX-10.14 4 ex_489418.htm EXHIBIT 10.14 ex_489418.htm Exhibit 10.14 February 22, 2023 Re: Separation from Employment and General Release Dear Chris, This letter agreement and general release (this "Agreement") sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, "Diffusion" or the "Company") effective March 1, 2023 (the "Separation Date"). References in this Agreement to "you" and "your" refer to Dr. Christopher D. Galloway, M.D. View More
Effective Date. You may revoke this Agreement for a period of seven (7) days following the day you sign it. If you choose to revoke this Agreement following execution, you must do so in writing, the writing must be received by Diffusion via e-mail to the Company's General Counsel, and it must be received by Diffusion within that seven (7) day period. Accordingly, this Agreement shall not become effective or enforceable until 12:00 a.m. on the eighth (8th) day following your signature hereof (the "Effective Date..."). [Remainder of Page Intentionally Left Blank] By signing this Agreement, you acknowledge that you have carefully reviewed this Agreement, that you have had an opportunity to consult with counsel of your choice, that you have entered into this Agreement freely and voluntarily and without reliance on any promises not expressly contained herein, that you have been afforded an adequate time to review carefully the terms of this Agreement, and that this Agreement will not be deemed void or avoidable by claims of duress, deception, mistake of fact or otherwise. Sincerely, DIFFUSION PHARMACEUTICALS INC. /s/ Robert J. Cobuzzi Robert J. Cobuzzi, Jr., Ph.D. Chief Executive Officer I have reviewed the Agreement as set forth above, I understand the Agreement, and, intending to be legally bound by my signature below, knowingly, and voluntarily accept all its terms and conditions. /s/ Christopher D. Galloway Raven Jaeger March 1, 2023 Name: Christopher D. Galloway, M.D. Raven Jaeger, M.S. Date EX-10.14 4 ex_489418.htm EX-10.15 5 ex_489419.htm EXHIBIT 10.14 ex_489418.htm 10.15 ex_489419.htm Exhibit 10.14 10.15 February 22, 16, 2023 Re: Separation from Employment and General Release Dear Chris, Raven, This letter agreement and general release (this "Agreement") sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, "Diffusion" or the "Company") effective March 1, 2023 (the "Separation Date"). References in this Agreement to "you" and "your" refer to Dr. Christopher D. Galloway, M.D. Ms. Raven Jaeger, M.S. View More
View Variation